期刊
JOURNAL OF EXPERIMENTAL MEDICINE
卷 201, 期 3, 页码 441-452出版社
ROCKEFELLER UNIV PRESS
DOI: 10.1084/jem.20041890
关键词
-
资金
- NCI NIH HHS [T32 CA009361, T32-CA09361] Funding Source: Medline
- NIGMS NIH HHS [R01-GM53415] Funding Source: Medline
CD45 is the prototypic member of transmembrane receptor-like protein tyrosine phosphatases (RPTPs) and has essential roles in immune functions. The cytoplasmic region of CD45, like many other RPTPs, contains two homologous protein tyrosine phosphatase domains, active domain 1 (D1) and catalytically impaired domain 2 (D2). Here, we report crystal structure of the cytoplasmic D1 D2 segment of human CD45 in native and phosphotyrosyl peptide-bound forms. The tertiary structures of 131 and D2 are very similar, but doubly phosphorylated CD3zeta immunoreceptor tyrosine-based activation motif peptide binds only the D1 active site. The D2 active site deviates from the other active sites significantly to the extent that excludes any possibility of catalytic activity. The relative orientation of D1 and D2 is very similar to that observed in leukocyte common antigen-related protein with both active sites in an open conformation and is restrained through an extensive network of hydrophobic interactions, hydrogen bonds, and salt bridges. This crystal structure is incompatible with the wedge model previously suggested for CD45 regulation.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据